Gut microbial characteristics of adult patients with allergy rhinitis

Abstract

Background Although recent studies have indicated that intestinal microbiota dweller are involved in the pathogenesis of allergy rhinitis (AR), the influence of gut microbiota on AR adult has not been fully elucidated yet. Hence, we carried out this study to uncover the distinctive bacterial taxa that differentiate allergy rhinitis patients from healthy individuals. Feces samples from thirty three AR patients and thirty one healthy individuals were analyzed by 16S rRNA gene sequencing. Results Results showed that the bacterial diversity in AR group was significantly higher than that of the non-AR group. Bacterial communities between AR and non-AR group were significantly differentiated as revealed by Principal coordinates analysis (PCoA) and the variation within non-AR were higher than that of the counterpart. Firmicutes, Fusobacteria, Actinobacteria, Cyanobacteria and Chloroflexi were the significantly differed phyla taxa and the top significantly distinguished bacterial genus included Prevotella_9, Phascolarctobacterium, Roseburia, Megamonas, Alistipes, Lachnoclostridium and Fusobacterium. The higher network complexity in AR group were dominated by taxa belonging to Firmicutes. The predicted function, alpha linolenic acid metabolism and bacterial invasion of epithelial cells pathway were higher in non-AR group while gonadotropin-releasing hormone (GnRH) signaling pathway, Fc γ-R mediated phagocytosis and endocytosis were higher in AR patients. Although the bacterial diversity between moderate and severe AR patients showed no significant difference, the significant correlation between featured genus and total nasal symptom score or rhinoconjunctivitis quality of life questionnaire, such as Butyricicoccus and Eisenbergiella, revealed the potential to intervene the AR status by means of gut microbiota. Conclusions In conclusion, patients with allergy rhinitis had distinguished gut microbiota characteritics in comparison with healthy controls. The results suggest that gut microbiota might play crucial roles in influencing the course and different symptoms of AR. Trial registration ChiCTR, ChiCTR1900028613. Registered 29 December 2019, https://www.chictr.org.cn/showproj.aspx?proj=47650.

Integrated Bacterial and Fungal Diversity Analysis Reveals the Gut Microbial Alterations in Diarrheic Giraffes

“…Generally, gut microbiota is dynamically diverse within limits and influenced by multiple factors such as species, age, sex, diet, and health status ( Manichanh et al, 2012 ; Wang et al, 2020 ; Xiong et al, 2020 ; Zhu et al, 2020 ). Several studies have indicated that diarrhea was able to cause a significant decrease in the diversity of gut bacterial community as well as shifts in intestinal functions ( Barash et al, 2017 ; He et al, 2020 ).…”

A Randomized Controlled Pilot Trial to Test the Efficacy of Intranasal Chlorpheniramine Maleate With Xylitol for the Treatment of Allergic Rhinitis

“…Furthermore, a complete microbiome analysis to detect the impact of CPM +X on the microbiome was not conducted, which is one of the study limitations. However, the impact of the microbiome in the pathogenesis of AR should not be overlooked as it has been gaining attention among researchers in the allergy and immunology fields [4,18,19].…”

Dynamic Microbial Shifts and Signatures of Long-Term Remission in Allergic Rhinitis After an Herbal Formula Treatment

“…Recruitment was undertaken via screening patients who randomly visit the authors' (LZ) TCM clinic or (LT and BY) otorhinolaryngology clinic. The inclusion and exclusion criteria for AR subjects were the same as the previous study (2). Treatment was delivered in the usual setting of the authors' (LZ) TCM clinic in Xiamen University Hospital (Xiamen, China).…”

“…The complex ecosystem of the commensal microbiota and its interactions with the host are fundamental in determining health (1). Gut microbiota imbalance has been associated with allergic disease, including allergic rhinitis (AR) (2,3). AR is characterized as an immunoglobulin E (IgE)mediated inflammatory response of the nasal mucous membranes after exposure to inhaled allergens, which is estimated to affect nearly one in every six Americans and generates $2 to $5 billion in direct health expenditures annually (4,5).…”